Concepedia

Paul Yeh

PY

Statistics

Publications

15

Citations

1.7K

H-Index

15

Active since

2015

Affiliations

Peter MacCallum Cancer Centre(Current)

The University of Melbourne

Walter and Eliza Hall Institute of Medical Research

GlaxoSmithKline (United States)

The Royal Melbourne Hospital

Paul Yeh is an author at Peter MacCallum Cancer Centre specializing in medicine, molecular oncology, and oncology.

ORCID

Publications per year

2015–2024

15

Publications

15

BET inhibitor resistance emerges from leukaemia stem cells

Chun Yew Fong, Omer Gilan, Enid Y.N. Lam et al. · Nature · 2015 · 548 citations · Full text

, , +14

Dynamic molecular monitoring reveals that SWI–SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma

Rishu Agarwal, Yih-Chih Chan, Constantine S. Tam et al. · Nature Medicine · 2018 · 204 citations · Full text

, , +17

Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia

Charles C. Bell, Katie Fennell, Yih-Chih Chan et al. · Nature Communications · 2019 · 180 citations · Full text

, , +17

HBO1 is required for the maintenance of leukaemia stem cells

Laura MacPherson, Juliana Anokye, Miriam M. Yeung et al. · Nature · 2019 · 174 citations · Full text

, , +11

Circulating Tumor DNA Analysis and Functional Imaging Provide Complementary Approaches for Comprehensive Disease Monitoring in Metastatic Melanoma

Stephen Q. Wong, Jeanette Raleigh, Jason Callahan et al. · JCO Precision Oncology · 2017 · 111 citations

, , +17

1–5 of 15